|
NUPL2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.482200E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.413670E-02 |
| Normal-vs-Stage2 |
3.013200E-01 |
| Normal-vs-Stage3 |
9.126600E-01 |
| Normal-vs-Stage4 |
5.688600E-01 |
| Stage1-vs-Stage2 |
9.928600E-01 |
| Stage1-vs-Stage3 |
1.932590E-01 |
| Stage1-vs-Stage4 |
6.465800E-01 |
| Stage2-vs-Stage3 |
3.717000E-01 |
| Stage2-vs-Stage4 |
7.174000E-01 |
| Stage3-vs-Stage4 |
6.942600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.235700E-03 |
| Normal-vs-AfricanAmerican |
7.120400E-02 |
| Normal-vs-Asian |
4.817500E-04 |
| Caucasian-vs-AfricanAmerican |
9.365800E-01 |
| Caucasian-vs-Asian |
1.892030E-01 |
| AfricanAmerican-vs-Asian |
2.748800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.497580E-03 |
| Normal-vs-Female |
1.385620E-01 |
| Male-vs-Female |
2.852200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.750800E-01 |
| Normal-vs-Extreme_Weight |
1.335970E-02 |
| Normal-vs-Obese |
2.114800E-01 |
| Normal-vs-Extreme_Obese |
6.000200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.893400E-01 |
| Normal_Weight-vs-Obese |
9.374800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.939200E-01 |
| Extreme_Weight-vs-Obese |
2.752400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.379000E-01 |
| Obese-vs-Extreme_Obese |
9.555400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.015800E-02 |
| Normal-vs-Age(41-60Yrs) |
2.970900E-04 |
| Normal-vs-Age(61-80Yrs) |
7.425700E-02 |
| Normal-vs-Age(81-100Yrs) |
6.154200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.755200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.196800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.787900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.037500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.492400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.049000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.46109999987765E-07 |
| Normal-VS-Type2 PRCC |
1.842220E-01 |
| Normal-VS-KIRP CIMP |
2.864500E-02 |
| Normal-VS-Unclassified PRCC |
2.765800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.29569999676826E-08 |
| Type1 PRCC-VS-KIRP CIMP |
1.683240E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.415800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.241800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.827500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.982400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.293800E-01 |
| Normal-vs-N1 |
5.810800E-01 |
| Normal-vs-N2 |
6.045400E-01 |
| N0-vs-N1 |
9.208800E-01 |
| N0-vs-N2 |
3.626400E-01 |
| N1-vs-N2 |
3.949600E-01 |
|
|
